April 6, 2005 — The U.S. Food and Drug Administration (FDA) announced in January revisions to safety labeling to advise healthcare professionals of the following changes: use of darbepoetin alfa ...
The studies compared the efficacy and safety of vadadustat to darbepoetin alfa in adult patients on dialysis with anemia due to CKD. Positive topline data were announced from the global phase 3 INNO 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results